PT1150680E - Utilizacao de moxonidima para o tratamento apos enfarte cardiaco - Google Patents

Utilizacao de moxonidima para o tratamento apos enfarte cardiaco

Info

Publication number
PT1150680E
PT1150680E PT00902638T PT00902638T PT1150680E PT 1150680 E PT1150680 E PT 1150680E PT 00902638 T PT00902638 T PT 00902638T PT 00902638 T PT00902638 T PT 00902638T PT 1150680 E PT1150680 E PT 1150680E
Authority
PT
Portugal
Prior art keywords
infarction
moxonidine
myocardial
physiologically compatible
myocardial infarction
Prior art date
Application number
PT00902638T
Other languages
English (en)
Inventor
Schoemaker Regina Gertruida
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of PT1150680E publication Critical patent/PT1150680E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Details Of Spanners, Wrenches, And Screw Drivers And Accessories (AREA)
  • Heat Treatment Of Articles (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fire-Extinguishing Compositions (AREA)
  • Farming Of Fish And Shellfish (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
PT00902638T 1999-02-01 2000-01-28 Utilizacao de moxonidima para o tratamento apos enfarte cardiaco PT1150680E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19903780 1999-02-01

Publications (1)

Publication Number Publication Date
PT1150680E true PT1150680E (pt) 2005-03-31

Family

ID=7895940

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00902638T PT1150680E (pt) 1999-02-01 2000-01-28 Utilizacao de moxonidima para o tratamento apos enfarte cardiaco

Country Status (26)

Country Link
US (1) US7041303B2 (pt)
EP (1) EP1150680B1 (pt)
JP (1) JP4686027B2 (pt)
KR (1) KR20010092793A (pt)
CN (1) CN1166363C (pt)
AT (1) ATE286731T1 (pt)
AU (1) AU774855B2 (pt)
BR (1) BR0007894A (pt)
CA (1) CA2361600C (pt)
CZ (1) CZ20012615A3 (pt)
DE (2) DE10003771A1 (pt)
DK (1) DK1150680T3 (pt)
ES (1) ES2235829T3 (pt)
HK (1) HK1042650B (pt)
HU (1) HUP0105210A3 (pt)
IL (1) IL144621A (pt)
NO (1) NO321061B1 (pt)
NZ (1) NZ513869A (pt)
PL (1) PL195124B1 (pt)
PT (1) PT1150680E (pt)
RU (1) RU2261097C2 (pt)
SK (1) SK10082001A3 (pt)
TR (1) TR200102221T2 (pt)
UA (1) UA67822C2 (pt)
WO (1) WO2000045820A1 (pt)
ZA (1) ZA200105827B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102850331B (zh) * 2012-09-17 2015-05-20 符爱清 一种化合物的制备方法
CN103483268B (zh) * 2013-09-17 2015-10-14 常州大学 一种4,6-二氯-2-甲基-5-硝基嘧啶的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3739779A1 (de) * 1987-11-24 1989-06-08 Beiersdorf Ag Pharmazeutische praeparate
AU3233197A (en) * 1996-06-06 1998-01-05 Eli Lilly And Company Formulation and method for treating congestive heart failure

Also Published As

Publication number Publication date
KR20010092793A (ko) 2001-10-26
AU2440400A (en) 2000-08-25
DE50009220D1 (de) 2005-02-17
HUP0105210A2 (hu) 2002-05-29
IL144621A (en) 2004-12-15
UA67822C2 (uk) 2004-07-15
ZA200105827B (en) 2002-07-16
IL144621A0 (en) 2002-05-23
NZ513869A (en) 2001-09-28
EP1150680B1 (de) 2005-01-12
ES2235829T3 (es) 2005-07-16
HK1042650A1 (en) 2002-08-23
WO2000045820A1 (de) 2000-08-10
PL350559A1 (en) 2002-12-16
NO321061B1 (no) 2006-03-06
JP2002536334A (ja) 2002-10-29
CN1338938A (zh) 2002-03-06
CA2361600A1 (en) 2000-08-10
DK1150680T3 (da) 2005-03-07
TR200102221T2 (tr) 2002-01-21
HK1042650B (zh) 2005-05-06
NO20013753L (no) 2001-09-28
DE10003771A1 (de) 2000-08-03
SK10082001A3 (sk) 2002-04-04
EP1150680A1 (de) 2001-11-07
RU2261097C2 (ru) 2005-09-27
US20020045633A1 (en) 2002-04-18
PL195124B1 (pl) 2007-08-31
AU774855B2 (en) 2004-07-08
CA2361600C (en) 2008-08-26
HUP0105210A3 (en) 2003-01-28
CN1166363C (zh) 2004-09-15
BR0007894A (pt) 2001-10-30
ATE286731T1 (de) 2005-01-15
JP4686027B2 (ja) 2011-05-18
CZ20012615A3 (cs) 2002-01-16
NO20013753D0 (no) 2001-07-31
US7041303B2 (en) 2006-05-09

Similar Documents

Publication Publication Date Title
BR0108452A (pt) Inibidores da oxidação parcial de ácido graxo no tratamento de insuficiência cardìaca congestiva
CY1109191T1 (el) Μια νεα χρηση της δεφεριπρονης
BR0212252A (pt) Métodos para reduzir a hipertensão e a insuficiência cardìaca em um mamìfero
ATE397938T1 (de) Behandlung des akuten koronaren syndroms mit glp- 1
SG156681A1 (en) Use of ranolazine in combination with at least one remodeling agent for reversing left ventricular remodeling in the treatment of heart failure
DE60137635D1 (de) Verwendung von allopurinol zur behandlung von bluthochdruck
BR0316458A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, método para intensificar a cognição em um paciente saudável, e, uso de um composto
MX2023012875A (es) Inhibidores 2-fluoro alquil-l,3,4-oxadiazol-5-il-tiazol de hdac6 para su uso en el tratamiento de enfermedades metabólicas y hfpef.
PT1150680E (pt) Utilizacao de moxonidima para o tratamento apos enfarte cardiaco
BR0316059A (pt) Uso de fosinopril para reduzir eventos cardiovasculares em pacientes de diálise
RU2002116408A (ru) Способ реперфузионной терапии больных острым инфарктом миокарда
ATE207353T1 (de) Verwendung von benzydamin zur behandlung von krankheitszuständen, die durch tnf verursacht werden
BR0303384A (pt) Citalopram e seus usos no tratamento de pressão sanguìnea elevada
Prescott Digoxin worthy of addition to ACEIs and diuretics in CHF
FI20010233A0 (fi) Menetelmä sydämen vajaatoiminnan hoitoon
SPLETE Draft Guidelines Address Pressure Ulcer Care
TH43264A (th) องค์ประกอบสำหรับการบำบัดรักษาแผลเรื้อรัง
CN1097990A (zh) 一种治疗股癣的药物
UA11290U (uk) Спосіб профілактики антрациклінового ушкодження серця
AR022475A1 (es) Metodo para la prevencion o reduccion de eventos cardiovasculares asociados con intervencion coronaria.
RU96102110A (ru) Способ профилактики и лечения изъязвлений роговицы
RU99122488A (ru) Способ лечения рака эндометрия
TH41860A (th) การใช้ขมิ้นชันหรือสารสกัดจากขมิ้นชันระงับและ/หรือรักษาโรคเก๊า และ/หรือลดกรดยูริคในเลือดในผู้ป่วยที่มีระดับกรดยูริคในเลือดสูง
RU98114654A (ru) Способ лечения туберкулеза легких
UA6306U (en) Method for treating disorders of hepatic blood circulation in patients with arterial hypertension and heart failure